Why resilience matters in Australia's evolving MRI landscape

Our healthcare system is operating in a different environment than it was just a few years ago.

As demand for diagnostic imaging continues to increase, workforce shortages in Australia remain a persistent challenge. Recent global supply chain disruptions highlight the importance of building resilience into critical healthcare infrastructure. These pressures are influencing how healthcare organizations evaluate major capital investments.

Rather than focusing solely on immediate acquisition costs or technical specifications, many providers in Australia are taking a longer-term view. Total cost of ownership, sustainability, operational continuity and workforce efficiency are becoming increasingly important considerations alongside clinical performance.

MRI is no exception.

Healthcare providers throughout Australia face the challenge of expanding access whilst ensuring imaging services remain dependable over the lifetime of the system. That means considering not only what an MRI scanner can do on the day it is installed, but how effectively it can continue supporting patients and clinicians over many years.

One of the least visible—but significant considerations in MRI infrastructure is liquid helium.

Conventional MRI systems typically require about 1,500 liters of liquid helium to cool the superconducting magnet, together with ongoing helium refill requirements throughout the system's operational lifetime³. As a finite resource with a globally concentrated supply chain, helium can introduce operational complexity and potential exposure to supply disruption and rising costs.

For providers operating across Australia's vast geography, where maintaining uninterrupted imaging services can be critical, reducing dependence on vulnerable supply chains is becoming an increasingly important consideration.

Resilience, in this context, is not simply about protecting infrastructure. It is about helping ensure patients continue to receive timely access to diagnosis and care.

Responding to these evolving healthcare priorities requires innovation that extends beyond imaging performance alone.

BlueSeal uses approximately seven litres of liquid helium permanently sealed within the magnet, eliminating the need for helium refills during normal operation.⁵ By significantly reducing reliance on a scarce resource, healthcare providers can reduce exposure to supply chain disruption while simplifying day-to-day operations.

The technology is already being adopted globally. Since 2019, more than 2,000 Philips BlueSeal MRI systems have been installed worldwide, helping save an estimated six million litres of helium.⁶ This reflects a broader shift in healthcare infrastructure towards technologies designed to improve long-term resilience alongside clinical capability.

Ultimately, resilience is about more than technology.

It is about helping healthcare providers continue delivering care when demand is high and resources are under pressure. This is particularly relevant in Australia, where regional and remote communities may rely on limited MRI capacity across large geographic areas. When a scanner becomes unavailable, patients may experience longer travel times, delayed diagnoses and additional pressure on already stretched healthcare services.

In this setting, technologies that reduce dependence on external supply chains and minimise operational complexity contribute to more reliable service continuity.

Dual-AI image reconstruction technology, enabling scan times to be reduced by up to three times while maintaining high image quality and diagnostic confidence.⁸ It also delivers more consistent image quality regardless of operator experience, helping streamline workflows and improve productivity.

Together, resilience and productivity are becoming complementary measures of modern MRI infrastructure. One helps ensure essential imaging services remain available. The other helps healthcare providers care for more patients using the resources they already have.

Australia's expansion of Medicare-funded MRI services represents one of the country's most significant investments in diagnostic imaging in recent decades.